
ChemMedChem p. 2864 - 2881 (2021)
Update date:2022-08-05
Topics:
Sun, Jufeng
Baker, Jennifer R.
Russell, Cecilia C.
Cossar, Peter J.
Ngoc Thuy Pham, Hong
Sakoff, Jennette A.
Scarlett, Christopher J.
McCluskey, Adam
In silico screening predicted 1 (N-(4-((4-(3-(4-(3-methoxyphenyl)-1H-1,2,3-triazol-1-yl)propyl)piperazin-1-yl) sulfonyl)-phenyl)acetamide) as an inhibitor of the S100A2-p53 protein-protein interaction. S100A2 is a validated pancreatic cancer drug target.
View MoreZhangjiagang Jianing Import & Export Co.,Ltd.
Contact:086-512-55379012 13913607595
Address:NO.1 Guotai North Road Zhangjiagang Economic Development Zone,215600,Jiangsu,China
Shijiazhuang Haotian Chemical Co., Ltd.
Contact:86-311-85044374
Address:293 Donggang Road
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Contact:+86-551-63633067
Address:Shuangfeng Road Hefei Anhui
Zhuhai Jiacheng Biological Technology Co., Ltd
Contact:0756-8800233
Address:room 222, Lianhua road , Gongbei ,Zhuhai, Guangdong ,China
Nanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Doi:10.1002/psc.1394
(2011)Doi:10.1039/c7cc09151f
(2018)Doi:10.1007/BF00772004
(1991)Doi:10.1021/ol047729n
(2005)Doi:10.3390/molecules17010884
(2012)Doi:10.1039/c2ob26147b
(2012)